{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:55:03Z","timestamp":1790787303379,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd011669","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,5,22]],"date-time":"2017-05-22T00:00:00Z","timestamp":1495411200000}}],"reference-count":132,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011669.pub2","type":"journal-article","created":{"date-parts":[[2017,5,22]],"date-time":"2017-05-22T13:40:04Z","timestamp":1495460404000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Morphine for chronic neuropathic pain in adults"],"prefix":"10.1002","volume":"2019","author":[{"given":"Tess E","family":"Cooper","sequence":"first","affiliation":[{"name":"The Children's Hospital at Westmead; Cochrane Kidney and Transplant, Centre for Kidney Research; Westmead NSW Australia 2145"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqiao","family":"Chen","sequence":"additional","affiliation":[{"name":"Evolent Health; 800 N Glebe Road Suite 500 Arlington Virginia USA 22203"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J","family":"Wiffen","sequence":"additional","affiliation":[{"name":"Thame UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheena","family":"Derry","sequence":"additional","affiliation":[{"name":"Oxford Oxfordshire UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel B","family":"Carr","sequence":"additional","affiliation":[{"name":"Tufts University School of Medicine; Pain Research, Education and Policy (PREP) Program, Department of Public Health and Community Medicine; Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Aldington","sequence":"additional","affiliation":[{"name":"Royal Hampshire County Hospital; Winchester UK SO22 5DG"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Cole","sequence":"additional","affiliation":[{"name":"Churchill Hospital, Oxford University Hospitals NHS Trust; Oxford Pain Relief Unit; Old Road Headington Oxford UK OX3 7LE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R Andrew","family":"Moore","sequence":"additional","affiliation":[{"name":"Plymouth UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,5,22]]},"reference":[{"issue":"13","key":"10.1002\/14651858.CD011669.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1056\/NEJMoa042580","article-title":"Morphine, gabapentin, or their combination for neuropathic pain","volume":"352","author":"Gilron","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD011669.pub2-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1097\/j.pain.0000000000000149","article-title":"Combination of morphine with nortriptyline for neuropathic pain","volume":"156","author":"Gilron","year":"2015","journal-title":"Pain"},{"issue":"1-2","key":"10.1002\/14651858.CD011669.pub2-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0304-3959(00)00385-7","article-title":"The effect of opioids on phantom limb pain and cortical reorganization","volume":"90","author":"Huse","year":"2001","journal-title":"Pain"},{"issue":"1-2","key":"10.1002\/14651858.CD011669.pub2-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.pain.2006.10.029","article-title":"Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain","volume":"130","author":"Khoromi","year":"2007","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD011669.pub2-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/ALN.0b013e31817f4523","article-title":"Morphine versus mexiletine for treatment of postamputation pain","volume":"109","author":"Wu","year":"2008","journal-title":"Anesthesiology"},{"issue":"4","key":"10.1002\/14651858.CD011669.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1212\/WNL.58.4.554","article-title":"Effects of IV morphine in central pain: a randomized placebo-controlled study","volume":"58","author":"Attal","year":"2002","journal-title":"Neurology"},{"issue":"9","key":"10.1002\/14651858.CD011669.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/0959-8049(94)90166-X","article-title":"Medical therapy of malignant nerve pain. A randomised double-blind explanatory trial with naproxen versus slow-release morphine","volume":"30A","author":"Dellemijn","year":"1994","journal-title":"European Journal of Cancer"},{"issue":"3","key":"10.1002\/14651858.CD011669.pub2-BIB0008|cit8","first-page":"214","article-title":"Morphine epidural block in lumbosacral pain","volume":"20","author":"Domzal","year":"1986","journal-title":"Neurologia i Neurochirurgia Polska"},{"issue":"3","key":"10.1002\/14651858.CD011669.pub2-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/0304-3959(94)90129-5","article-title":"Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo","volume":"58","author":"Eide","year":"1994","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD011669.pub2-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.pain.2005.03.004","article-title":"MorphiDex (morphine sulfate\/dextromethorphan hydrobromide combination) in the treatment of chronic pain: three multicenter, randomized, double-blind, controlled clinical trials fail to demonstrate enhanced opioid analgesia or reduction in tolerance","volume":"115","author":"Galer","year":"2005","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD011669.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1213\/00000539-200102000-00039","article-title":"The response of neuropathic pain and pain in complex regional pain syndrome I to carbamazepine and sustained-release morphine in patients pretreated with spinal cord stimulation: a double-blinded randomized study","volume":"92","author":"Harke","year":"2001","journal-title":"Anesthesia and Analgesia"},{"issue":"8806","key":"10.1002\/14651858.CD011669.pub2-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/0140-6736(92)91194-D","article-title":"Morphine responsiveness of chronic pain: double-blind randomised crossover study with patient-controlled analgesia","volume":"339","author":"Jadad","year":"1992","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD011669.pub2-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1053\/eujp.2001.0307","article-title":"Morphine responsiveness in a group of well-defined multiple sclerosis patients: a study with i.v. morphine","volume":"6","author":"Kalman","year":"2002","journal-title":"European Journal of Pain"},{"issue":"1","key":"10.1002\/14651858.CD011669.pub2-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.5055\/jom.2013.0416","article-title":"Open-label study to evaluate the efficacy and safety of extended-release hydromorphone in patients with chronic neuropathic pain","volume":"9","author":"Nalamachu","year":"2013","journal-title":"Journal of Opioid Management"},{"issue":"1","key":"10.1002\/14651858.CD011669.pub2-BIB0015|cit15","first-page":"40","article-title":"Multimodal approach to therapy-related neuropathic pain in breast cancer","volume":"16","author":"Patarica-Huber","year":"2011","journal-title":"Journal of B.U.ON."},{"issue":"7","key":"10.1002\/14651858.CD011669.pub2-BIB0016|cit16","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/j.1399-6576.1998.tb05317.x","article-title":"The analgesic effect of racemic ketamine in patients with chronic ischemic pain due to lower extremity arteriosclerosis obliterans","volume":"42","author":"Persson","year":"1998","journal-title":"Acta Anaesthesiologica Scandinavia"},{"issue":"7","key":"10.1002\/14651858.CD011669.pub2-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1212\/WNL.59.7.1015","article-title":"Opioids versus antidepressants in postherpetic neuralgia","volume":"59","author":"Raja","year":"2002","journal-title":"Neurology"},{"issue":"11","key":"10.1002\/14651858.CD011669.pub2-BIB0018|cit18","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.1016\/j.pain.2014.08.015","article-title":"Thoracic sympathetic block for the treatment of complex regional pain syndrome type I: a double-blind randomized controlled study","volume":"155","author":"Rocha Rde","year":"2014","journal-title":"Pain"},{"issue":"7","key":"10.1002\/14651858.CD011669.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1212\/WNL.41.7.1024","article-title":"Both intravenous lidocaine and morphine reduce the pain of postherpetic neuralgia","volume":"41","author":"Rowbotham","year":"1991","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD011669.pub2-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/acem.12956","article-title":"Comparison of intravenous morphine versus paracetamol in sciatica: a randomized placebo controlled trial","volume":"23","author":"Serinken","year":"2016","journal-title":"Academic Emergency Medicine"},{"issue":"6","key":"10.1002\/14651858.CD011669.pub2-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1097\/00000539-200012000-00037","article-title":"The efficacy of intrathecal morphine and clonidine in the treatment of pain after spinal cord injury","volume":"91","author":"Siddall","year":"2000","journal-title":"Anesthesia and Analgesia"},{"issue":"3","key":"10.1002\/14651858.CD011669.pub2-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/j.1526-4637.2006.00154.x","article-title":"The association between psychopathology and placebo analgesia in patients with discogenic low back pain","volume":"7","author":"Wasan","year":"2006","journal-title":"Pain Medicine"},{"issue":"7","key":"10.1002\/14651858.CD011669.pub2-BIB0023|cit23","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/j.1365-2044.1996.tb07846.x","article-title":"Epidural morphine for postherpetic neuralgia","volume":"51","author":"Watt","year":"1996","journal-title":"Anaesthesia"},{"issue":"2","key":"10.1002\/14651858.CD011669.pub2-BIB0024|cit24","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1097\/00000542-200204000-00010","article-title":"Analgesic effects of intravenous lidocaine and morphine on postamputation pain","volume":"96","author":"Wu","year":"2002","journal-title":"Anesthesiology"},{"issue":"21","key":"10.1002\/14651858.CD011669.pub2-BIB0025|cit25","first-page":"1877","article-title":"Efficacy and safety of oxycodone-acetaminophen tablet in 142 patients with different types of moderate and advanced cancer pain","volume":"17","author":"Xiong","year":"2008","journal-title":"Chinese Journal of New Drugs"},{"issue":"2","key":"10.1002\/14651858.CD011669.pub2-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.ijcard.2012.11.048","article-title":"Random error in cardiovascular meta-analyses: how common are false positive and false negative results?","volume":"168","author":"AlBalawi","year":"2013","journal-title":"International Journal of Cardiology"},{"issue":"8432","key":"10.1002\/14651858.CD011669.pub2-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/S0140-6736(85)91448-5","article-title":"Renal failure and the use of morphine in intensive care","volume":"1","author":"Ball","year":"1985","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD011669.pub2-BIB0028|cit28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S1474-4422(11)70281-2","article-title":"Chronic pain: genes, plasticity, and phenotypes","volume":"11","author":"Baron","year":"2012","journal-title":"Lancet Neurology"},{"issue":"2","key":"10.1002\/14651858.CD011669.pub2-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/j.pain.0000000000000753","article-title":"Peripheral neuropathic pain: a mechanism-related organizing principle based on sensory profiles","volume":"158","author":"Baron","year":"2017","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD011669.pub2-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jpain.2003.12.004","article-title":"Clinical characteristics and economic costs of patients with painful neuropathic disorders","volume":"5","author":"Berger","year":"2004","journal-title":"Journal of Pain"},{"issue":"1","key":"10.1002\/14651858.CD011669.pub2-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1533-2500.2008.00244.x","article-title":"Clinical and economic characteristics of patients with painful neuropathic disorders in Germany","volume":"9","author":"Berger","year":"2009","journal-title":"Pain Practice"},{"key":"10.1002\/14651858.CD011669.pub2-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1471-2377-12-8","article-title":"Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders in UK general practice: a retrospective cohort study","volume":"12","author":"Berger","year":"2012","journal-title":"BMC Neurology"},{"issue":"3","key":"10.1002\/14651858.CD011669.pub2-BIB0033|cit33","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.pain.2007.08.013","article-title":"Prevalence of chronic pain with neuropathic characteristics in the general population","volume":"136","author":"Bouhassira","year":"2008","journal-title":"Pain"},{"issue":"1","key":"10.1002\/14651858.CD011669.pub2-BIB0034|cit34","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/ije\/dyn188","article-title":"Apparently conclusive meta-analyses may be inconclusive - Trial Sequential Analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses","volume":"38","author":"Brok","year":"2009","journal-title":"International Journal of Epidemiology"},{"issue":"7","key":"10.1002\/14651858.CD011669.pub2-BIB0035|cit35","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1474-4422(12)70134-5","article-title":"The role of the immune system in the generation of neuropathic pain","volume":"11","author":"Calvo","year":"2012","journal-title":"Lancet Neurology"},{"issue":"7","key":"10.1002\/14651858.CD011669.pub2-BIB0036|cit36","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008943.pub2","article-title":"Combination pharmacotherapy for the treatment of neuropathic pain in adults","author":"Chaparro","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"6","key":"10.1002\/14651858.CD011669.pub2-BIB0037|cit37","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S0885-3924(98)00094-3","article-title":"Peak plasma concentrations after oral morphine: a systematic review","volume":"16","author":"Collins","year":"1998","journal-title":"Journal of Pain and Symptom Management"},{"key":"10.1002\/14651858.CD011669.pub2-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"17002","DOI":"10.1038\/nrdp.2017.2","article-title":"Neuropathic pain","volume":"3","author":"Colloca","year":"2017","journal-title":"Nature Reviews Disease Primers"},{"key":"10.1002\/14651858.CD011669.pub2-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"f2304","DOI":"10.1136\/bmj.f2304","article-title":"Influence of trial sample size on treatment effect estimates: meta-epidemiological study","volume":"346","author":"Dechartres","year":"2013","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011669.pub2-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1001\/jama.2014.8166","article-title":"Association between analytic strategy and estimates of treatment outcomes in meta-analyses","volume":"312","author":"Dechartres","year":"2014","journal-title":"JAMA"},{"issue":"11","key":"10.1002\/14651858.CD011669.pub2-BIB0041|cit41","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1016\/j.pain.2014.08.014","article-title":"The effect of oxcarbazepine in peripheral neuropathic pain depends on pain phenotype: a randomised, double-blind, placebo-controlled phenotype-stratified study","volume":"155","author":"Demant","year":"2014","journal-title":"Pain"},{"issue":"9","key":"10.1002\/14651858.CD011669.pub2-BIB0042|cit42","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010111","article-title":"Topical capsaicin (low concentration) for chronic neuropathic pain in adults","author":"Derry","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD011669.pub2-BIB0043|cit43","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010958.pub2","article-title":"Topical lidocaine for neuropathic pain in adults","author":"Derry","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD011669.pub2-BIB0044|cit44","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011605.pub2","article-title":"Fentanyl for neuropathic pain in adults","author":"Derry","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD011669.pub2-BIB0045|cit45","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007393.pub4","article-title":"Topical capsaicin (high concentration) for chronic neuropathic pain in adults","author":"Derry","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD011669.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"Journal of Pain"},{"issue":"11","key":"10.1002\/14651858.CD011669.pub2-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1016\/j.pain.2013.06.004","article-title":"Interventional management of neuropathic pain: NeuPSIG recommendations","volume":"154","author":"Dworkin","year":"2013","journal-title":"Pain"},{"issue":"12","key":"10.1002\/14651858.CD011669.pub2-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1345\/aph.1P777","article-title":"Systematic review and meta-analysis of efficacy, safety, and tolerability data from randomized controlled trials of drugs used to treat postherpetic neuralgia","volume":"45","author":"Edelsberg","year":"2011","journal-title":"Annals of Pharmacotherapy"},{"issue":"1","key":"10.1002\/14651858.CD011669.pub2-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"7","key":"10.1002\/14651858.CD011669.pub2-BIB0050|cit50","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012299","article-title":"High-dose opioids for chronic non-cancer pain: an overview of Cochrane reviews","author":"Els","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011669.pub2-BIB0051|cit51","unstructured":"Effective Practice Organisation of Care (EPOC) 23. Worksheets for preparing a Summary of Findings using GRADE. Resources for review authors, 2015 Oslo: Norwegian Knowledge Centre for the Health Services. Available at: epoc.cochrane.org\/epoc-specific-resources-review-authors"},{"issue":"2","key":"10.1002\/14651858.CD011669.pub2-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0885-3924(95)00148-4","article-title":"Morphine and morphine-6-glucuronide plasma concentrations and effect in cancer pain","volume":"11","author":"Faura","year":"1996","journal-title":"Journal of Pain and Symptom Management"},{"issue":"1","key":"10.1002\/14651858.CD011669.pub2-BIB0053|cit53","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0304-3959(97)00142-5","article-title":"Systematic review of factors affecting the ratios of morphine and its major metabolites","volume":"74","author":"Faura","year":"1998","journal-title":"Pain"},{"issue":"7","key":"10.1002\/14651858.CD011669.pub2-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1002\/j.1532-2149.2012.00282.x","article-title":"Neuropathic pain needs systematic classification","volume":"17","author":"Finnerup","year":"2013","journal-title":"European Journal of Pain"},{"issue":"2","key":"10.1002\/14651858.CD011669.pub2-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurology"},{"issue":"14","key":"10.1002\/14651858.CD011669.pub2-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1212\/WNL.0000000000000839","article-title":"Opioids for chronic noncancer pain: a position paper of the American Academy of Neurology","volume":"83","author":"Franklin","year":"2014","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD011669.pub2-BIB0057|cit57","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010692.pub2","article-title":"Oxycodone for neuropathic pain and fibromyalgia in adults","author":"Gaskell","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD011669.pub2-BIB0058|cit58","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010692.pub3","article-title":"Oxycodone for neuropathic pain in adults","author":"Gaskell","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011669.pub2-BIB0059|cit59","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780192632340.001.0001","volume-title":"Oxford Textbook of Clinical Pharmacology and Drug Therapy","author":"Grahame-Smith","year":"2002"},{"issue":"1","key":"10.1002\/14651858.CD011669.pub2-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1399-6576.2007.01486.x","article-title":"Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey","volume":"52","author":"Gustorff","year":"2008","journal-title":"Acta Anaesthesiologica Scandinavica"},{"issue":"12","key":"10.1002\/14651858.CD011669.pub2-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","article-title":"GRADE guidelines: 7. Rating the quality of evidence - inconsistency","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD011669.pub2-BIB0062|cit62","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jclinepi.2012.01.006","article-title":"GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD011669.pub2-BIB0063|cit63","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jclinepi.2012.01.012","article-title":"GRADE guidelines: 12. Preparing summary of findings tables - binary outcomes","volume":"66","author":"Guyatt","year":"2013","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD011669.pub2-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1471-2296-9-26","article-title":"Primary care incidence and treatment of four neuropathic pain conditions: a descriptive study, 2002-2005","volume":"9","author":"Hall","year":"2008","journal-title":"BMC Family Practice"},{"key":"10.1002\/14651858.CD011669.pub2-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1471-2296-14-28","article-title":"An observational descriptive study of the epidemiology and treatment of neuropathic pain in a UK general population","volume":"14","author":"Hall","year":"2013","journal-title":"BMC Family Practice"},{"issue":"8569","key":"10.1002\/14651858.CD011669.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0140-6736(87)91341-9","article-title":"Potential analgesic contribution from morphine-6-glucuronide in CSF","volume":"2","author":"Hand","year":"1987","journal-title":"Lancet"},{"issue":"11","key":"10.1002\/14651858.CD011669.pub2-BIB0067|cit67","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008025.pub2","article-title":"Methadone for chronic non-cancer pain in adults","author":"Haroutiunian","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD011669.pub2-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/cpt.19","article-title":"Individualized pharmacological treatment of neuropathic pain","volume":"97","author":"Helfert","year":"2015","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD011669.pub2-BIB0069|cit69","unstructured":"Higgins JP Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"2","key":"10.1002\/14651858.CD011669.pub2-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.pain.2009.09.017","article-title":"How do changes in pain severity levels correspond to changes in health status and function in patients with painful diabetic peripheral neuropathy?","volume":"149","author":"Hoffman","year":"2010","journal-title":"Pain"},{"issue":"1","key":"10.1002\/14651858.CD011669.pub2-BIB0071|cit71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD011669.pub2-BIB0072|cit72","doi-asserted-by":"crossref","unstructured":"Jensen TS Baron R Haanp\u00e4\u00e4 M Kalso E Loeser JD Rice AS A new definition of neuropathic pain Pain 2011 2204 5 10.1016\/j.pain.2011.06.017","DOI":"10.1016\/j.pain.2011.06.017"},{"key":"10.1002\/14651858.CD011669.pub2-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"f7339","DOI":"10.1136\/bmj.f7339","article-title":"Drugs for neuropathic pain","volume":"347","author":"Kalso","year":"2013","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD011669.pub2-BIB0074|cit74","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1159\/000110284","article-title":"Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota, 1945-1984","volume":"10","author":"Katusic","year":"1991","journal-title":"Neuroepidemiology"},{"issue":"6","key":"10.1002\/14651858.CD011669.pub2-BIB0075|cit75","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1093\/bja\/aeu186","article-title":"Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide","volume":"113","author":"Klimas","year":"2014","journal-title":"British Journal of Anaesthesia"},{"issue":"1-3","key":"10.1002\/14651858.CD011669.pub2-BIB0076|cit76","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.pain.2009.08.023","article-title":"Incidence of facial pain in the general population","volume":"147","author":"Koopman","year":"2009","journal-title":"Pain"},{"key":"10.1002\/14651858.CD011669.pub2-BIB0077|cit77","doi-asserted-by":"publisher","first-page":"224","DOI":"10.7326\/0003-4819-107-2-224","article-title":"Meta-analysis in clinical research","volume":"107","author":"L'Abb\u00e9","year":"1987","journal-title":"Annals of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD011669.pub2-BIB0078|cit78","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s12325-010-0036-3","article-title":"Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back pain","volume":"27","author":"Lange","year":"2010","journal-title":"Advances in Therapy"},{"issue":"1","key":"10.1002\/14651858.CD011669.pub2-BIB0079|cit79","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007115.pub3","article-title":"Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia","author":"Lunn","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD011669.pub2-BIB0080|cit80","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006146.pub2","article-title":"Opioids for neuropathic pain","author":"McNicol","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011669.pub2-BIB0081|cit81","volume-title":"An Evidence-Based Resource for Pain Relief","author":"McQuay","year":"1998"},{"key":"10.1002\/14651858.CD011669.pub2-BIB0082|cit82","article-title":"Chronic pain","volume-title":"Health Care Needs Assessment, 3rd Series","author":"McQuay","year":"2007"},{"issue":"3","key":"10.1002\/14651858.CD011669.pub2-BIB0083|cit83","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0304-3959(98)00140-7","article-title":"Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects","volume":"78","author":"Moore","year":"1998","journal-title":"Pain"},{"key":"10.1002\/14651858.CD011669.pub2-BIB0084|cit84","first-page":"15","article-title":"Managing potential publication bias","volume-title":"Systematic Reviews in Pain Research: Methodology Refined","author":"Moore","year":"2008"},{"issue":"3","key":"10.1002\/14651858.CD011669.pub2-BIB0085|cit85","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007076.pub2","article-title":"Pregabalin for acute and chronic pain in adults","author":"Moore","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD011669.pub2-BIB0086|cit86","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.pain.2010.05.011","article-title":"\"Evidence\" in chronic pain - establishing best practice in the reporting of systematic reviews","volume":"150","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD011669.pub2-BIB0087|cit87","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.pain.2010.02.032","article-title":"Chronic low back pain analgesic studies - a methodological minefield","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD011669.pub2-BIB0088|cit88","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.pain.2010.02.039","article-title":"Fibromyalgia: moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD011669.pub2-BIB0089|cit89","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.pain.2010.07.013","article-title":"Numbers-needed-to-treat analyses - do timing, dropouts, and outcome matter? Pooled analysis of two randomized, placebo-controlled chronic low back pain trials","volume":"151","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD011669.pub2-BIB0090|cit90","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1136\/ard.2009.107805","article-title":"Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice","volume":"69","author":"Moore","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"5","key":"10.1002\/14651858.CD011669.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.pain.2010.11.030","article-title":"Minimum efficacy criteria for comparisons between treatments using individual patient meta-analysis of acute pain trials: examples of etoricoxib, paracetamol, ibuprofen, and ibuprofen\/paracetamol combinations after third molar extraction","volume":"152","author":"Moore","year":"2011","journal-title":"Pain"},{"issue":"6","key":"10.1002\/14651858.CD011669.pub2-BIB0092|cit92","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1097\/EJA.0b013e328343c569","article-title":"Mean analgesic consumption is inappropriate for testing analgesic efficacy in post-operative pain: analysis and alternative suggestion","volume":"28","author":"Moore","year":"2011","journal-title":"European Journal of Anaesthesiology"},{"issue":"2","key":"10.1002\/14651858.CD011669.pub2-BIB0093|cit93","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.pain.2011.10.004","article-title":"Estimate at your peril: imputation methods for patient withdrawal can bias efficacy outcomes in chronic pain trials using responder analyses","volume":"153","author":"Moore","year":"2012","journal-title":"Pain"},{"key":"10.1002\/14651858.CD011669.pub2-BIB0094|cit94","doi-asserted-by":"publisher","first-page":"f2690","DOI":"10.1136\/bmj.f2690","article-title":"Expect analgesic failure; pursue analgesic success","volume":"346","author":"Moore","year":"2013","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD011669.pub2-BIB0095|cit95","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1111\/anae.12148","article-title":"Pain measures and cut-offs - 'no worse than mild pain' as a simple, universal outcome","volume":"68","author":"Moore","year":"2013","journal-title":"Anaesthesia"},{"issue":"1","key":"10.1002\/14651858.CD011669.pub2-BIB0096|cit96","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/papr.12050","article-title":"The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain","volume":"14","author":"Moore","year":"2014","journal-title":"Pain Practice"},{"issue":"1","key":"10.1002\/14651858.CD011669.pub2-BIB0097|cit97","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/j.1532-2149.2013.00341.x","article-title":"Duloxetine use in chronic painful conditions - individual patient data responder analysis","volume":"18","author":"Moore","year":"2014","journal-title":"European Journal of Pain"},{"issue":"4","key":"10.1002\/14651858.CD011669.pub2-BIB0098|cit98","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007938.pub3","article-title":"Gabapentin for chronic neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD011669.pub2-BIB0099|cit99","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010902.pub2","article-title":"Oral nonsteroidal anti-inflammatory drugs for neuropathic pain","author":"Moore","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD011669.pub2-BIB0100|cit100","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008242.pub3","article-title":"Amitriptyline for neuropathic pain in adults","author":"Moore","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD011669.pub2-BIB0101|cit101","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1097\/j.pain.0000000000000088","article-title":"Systematic review of enriched enrolment, randomised withdrawal trial designs in chronic pain: a new framework for design and reporting","volume":"156","author":"Moore","year":"2015","journal-title":"Pain"},{"key":"10.1002\/14651858.CD011669.pub2-BIB0102|cit102","unstructured":"National Institute for Health and Care Excellence (NICE) Neuropathic pain - pharmacological management: the pharmacological management of neuropathic pain in adults in non-specialist settings, 2013 (updated 2017) nice.org.uk\/guidance\/cg173"},{"key":"10.1002\/14651858.CD011669.pub2-BIB0103|cit103","doi-asserted-by":"publisher","first-page":"c3515","DOI":"10.1136\/bmj.c3515","article-title":"Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study","volume":"341","author":"N\u00fcesch","year":"2010","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD011669.pub2-BIB0104|cit104","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/j.1526-4637.2009.00685","article-title":"Patient-centered perspective on treatment outcomes in chronic pain","volume":"11","author":"O'Brien","year":"2010","journal-title":"Pain Medicine"},{"issue":"4","key":"10.1002\/14651858.CD011669.pub2-BIB0105|cit105","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1037\/h0026860","article-title":"Classical statistical hypothesis testing within the context of Bayesian theory","volume":"71","author":"Overall","year":"1969","journal-title":"Psychological Bulletin"},{"key":"10.1002\/14651858.CD011669.pub2-BIB0106|cit106","unstructured":"Cochrane Pain, Palliative and Supportive Care Group (PaPaS) author and referee guidance papas.cochrane.org\/papas-documents"},{"issue":"2","key":"10.1002\/14651858.CD011669.pub2-BIB0107|cit107","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/0304-3959(94)90086-8","article-title":"Trigeminal neuralgia: the role of self-sustaining discharge in the trigeminal ganglion","volume":"56","author":"Rappaport","year":"1994","journal-title":"Pain"},{"key":"10.1002\/14651858.CD011669.pub2-BIB0108|cit108","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"key":"10.1002\/14651858.CD011669.pub2-BIB0109|cit109","volume-title":"History of Pain","author":"Rey","year":"1993"},{"key":"10.1002\/14651858.CD011669.pub2-BIB0110|cit110","doi-asserted-by":"publisher","first-page":"h2463","DOI":"10.1136\/bmj.h2463","article-title":"The knowledge system underpinning healthcare is not fit for purpose and must change","volume":"350","author":"Roberts","year":"2015","journal-title":"BMJ"},{"issue":"9","key":"10.1002\/14651858.CD011669.pub2-BIB0111|cit111","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.vaccine.2005.09.026","article-title":"The burden of herpes zoster: a prospective population based study","volume":"24","author":"Scott","year":"2006","journal-title":"Vaccine"},{"issue":"1","key":"10.1002\/14651858.CD011669.pub2-BIB0112|cit112","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/bja\/62.1.28","article-title":"Studies on morphine disposition: influence of renal failure on the kinetics of morphine and its metabolites","volume":"62","author":"Sear","year":"1989","journal-title":"British Journal of Anaesthesia"},{"issue":"1","key":"10.1002\/14651858.CD011669.pub2-BIB0113|cit113","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00482-014-1455-x","article-title":"Opioids in chronic neuropathic pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration","volume":"29","author":"Sommer","year":"2015","journal-title":"Schmerz (Berlin, Germany)"},{"issue":"7","key":"10.1002\/14651858.CD011669.pub2-BIB0114|cit114","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1002\/art.37962","article-title":"Neuropathic features of joint pain: a community-based study","volume":"65","author":"Soni","year":"2013","journal-title":"Arthritis and Rheumatism"},{"issue":"5","key":"10.1002\/14651858.CD011669.pub2-BIB0115|cit115","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011604.pub2","article-title":"Hydromorphone for neuropathic pain in adults","author":"Stannard","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD011669.pub2-BIB0116|cit116","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1365-2125.2008.03200","article-title":"Enriched enrolment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review","volume":"66","author":"Straube","year":"2008","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD011669.pub2-BIB0117|cit117","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/1471-2474-11-150","article-title":"Pregabalin in fibromyalgia - responder analysis from individual patient data","volume":"11","author":"Straube","year":"2010","journal-title":"BMC Musculoskeletal Disorders"},{"key":"10.1002\/14651858.CD011669.pub2-BIB0118|cit118","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2377-8-9","article-title":"Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials","volume":"8","author":"Sultan","year":"2008","journal-title":"BMC Neurology"},{"issue":"11","key":"10.1002\/14651858.CD011669.pub2-BIB0119|cit119","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1093\/pm\/pnw245","article-title":"Durations of opioid, nonopioid drug, and behavioral clinical trials for chronic pain: adequate or inadequate?","volume":"17","author":"Tayeb","year":"2016","journal-title":"Pain Medicine"},{"issue":"10","key":"10.1002\/14651858.CD011669.pub2-BIB0120|cit120","doi-asserted-by":"publisher","first-page":"e25491","DOI":"10.1371\/journal.pone.0025491","article-title":"The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis - a simulation study","volume":"6","author":"Thorlund","year":"2011","journal-title":"PloS One"},{"issue":"4","key":"10.1002\/14651858.CD011669.pub2-BIB0121|cit121","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.jpain.2005.11.008","article-title":"The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey","volume":"7","author":"Torrance","year":"2006","journal-title":"Journal of Pain"},{"issue":"18","key":"10.1002\/14651858.CD011669.pub2-BIB0122|cit122","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1212\/01.wnl.0000282763.29778.59","article-title":"Neuropathic pain: redefinition and a grading system for clinical and research purposes","volume":"70","author":"Treede","year":"2008","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD011669.pub2-BIB0123|cit123","doi-asserted-by":"publisher","first-page":"e59202","DOI":"10.1371\/journal.pone.0059202","article-title":"The impact of study size on meta-analyses: examination of underpowered studies in Cochrane reviews","volume":"8","author":"Turner","year":"2013","journal-title":"PloS One"},{"issue":"4","key":"10.1002\/14651858.CD011669.pub2-BIB0124|cit124","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.pain.2013.11.013","article-title":"Neuropathic pain in the general population: a systematic review of epidemiological studies","volume":"155","author":"Hecke","year":"2014","journal-title":"Pain"},{"issue":"9","key":"10.1002\/14651858.CD011669.pub2-BIB0125|cit125","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/j.vaccine.2008.12.024","article-title":"Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales","volume":"27","author":"Hoek","year":"2009","journal-title":"Vaccine"},{"issue":"4","key":"10.1002\/14651858.CD011669.pub2-BIB0126|cit126","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.neuron.2012.02.008","article-title":"Deconstructing the neuropathic pain phenotype\u00a0to reveal neural mechanisms","volume":"73","author":"Hehn","year":"2012","journal-title":"Neuron"},{"issue":"9859","key":"10.1002\/14651858.CD011669.pub2-BIB0127|cit127","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Vos","year":"2012","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD011669.pub2-BIB0128|cit128","unstructured":"World Health Organization Cancer Pain Relief, 1986 who.int\/iris\/handle\/10665\/43944"},{"key":"10.1002\/14651858.CD011669.pub2-BIB0129|cit129","unstructured":"World Health Organization WHO Essential Medicines List 17th edition, 2011 whqlibdoc.who.int\/hq\/2011\/a95053_eng.pdf"},{"issue":"11","key":"10.1002\/14651858.CD011669.pub2-BIB0130|cit130","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010567.pub2","article-title":"Antiepileptic drugs for neuropathic pain and fibromyalgia - an overview of Cochrane reviews","author":"Wiffen","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD011669.pub2-BIB0131|cit131","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011603.pub2","article-title":"Buprenorphine for neuropathic pain in adults","author":"Wiffen","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD011669.pub2-BIB0132|cit132","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012227.pub2","article-title":"Paracetamol (acetaminophen) with or without codeine or dihydrocodeine for neuropathic pain in adults","author":"Wiffen","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD011669.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T07:45:15Z","timestamp":1719215115000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011669.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,5,22]]},"references-count":132,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011669.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,22]]}}}